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Background: Shigella flexneri is the major cause of shigellosis in the developing countries. The O-antigen
component of the lipopolysaccharide is one of the key virulence determinants required for the pathogenesis of S.
flexneri. The glucosyltransferase and/or acetyltransferase genes responsible for the modification of the O-antigen are
encoded by temperate serotype converting bacteriophage present in the S. flexneri genome. Several serotype
converting phages have previously been isolated and characterized, however, attempts to isolate a serotype
converting phage which encodes the modification genes of serotypes 4a strain have not been successful.
Results: In this study, a novel temperate serotype converting bacteriophage SfIV was isolated. Lysogenisation of
phage SfIV converted serotype Y strain to serotype 4a. Electron microscopy indicated that SfIV belongs to
Myoviridae family. The 39,758 bp genome of phage SfIV encompasses 54 open reading frames (orfs). Protein level
comparison of SfIV with other serotype converting phages of S. flexneri revealed that SfIV is similar to phage SfII and
SfV. The comparative analysis also revealed that SfIV phage contained five proteins which were not found in any
other phages of S. flexneri. These proteins were: a tail fiber assembly protein, two hypothetical proteins with no
clear function, and two other unknown proteins which were encoded by orfs present on a moron, that presumably
got introduced in SfIV genome from another species via a transposon. These unique proteins of SfIV may play a
role in the pathogenesis of the host.
Conclusions: This study reports the isolation and complete genome sequence analysis of bacteriophage SfIV. The
SfIV phage has a host range significantly different from the other phages of Shigella. Comparative genome analysis
identified several proteins unique to SfIV, which may potentially be involved in the survival and pathogenesis of its
host. These findings will further our understanding on the evolution of these phages, and will also facilitate studies
on development of new phage vectors and therapeutic agents to control infections caused by S. flexneri.
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Shigella diarrhoeal illness continues to be a leading
cause of morbidity and mortality worldwide, particularly
in the developing countries. Annually there are esti-
mated 7 million cases of shigellosis globally, of which 1.1
million result in death. Shigella encompasses four sub-
groups (S. boydii, S. dysenteriae, S. flexneri, and S. sonnei)
[1]. Although S. dysenteriae type 1 is associated with the* Correspondence: naresh.verma@anu.edu.au
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reproduction in any medium, provided the ormost severe form of the disease and high mortality rate
when epidemics occur, most of the deaths are attributed
to the endemic form of the disease, which is most often
caused by S. flexneri [2].
Based on the O-antigen structure of the lipopolysac-
charide (LPS) molecule, S. flexneri is currently divided
into 17 serotypes [3-5]. All the serotypes, with an excep-
tion of serotype 6, share a common O-antigen backbone
comprising of repeating tetrasaccharide units (N-
acetylglucosamine attached to three rhamnose residues)
[6]. Modifications to the basic O-antigen backbone,
which occur through glucosylation and/or O-acetylation
of one or more sugars within the repeating unit, forml Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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to occur only on rhamnose III residue, while glu-
cosylation can occur on any of the three rhamnoses or
on the N-acetylglucosamine. The genes which mediate
the addition of glucosyl or O-acetyl residues to the spe-
cific sugars are encoded by temperate bacteriophage.
These phage are integrated into the host chromosome,
forming a prophage that stably expresses serotype con-
version genes [7].
The glucosylation loci in these phages contain three
genes [gtrA, gtrB, and gtr(type)] that are arranged in a
single operon known as a gtr cluster. The first two
genes, gtrA and gtrB, which encode proteins involved in
transferring the glucosyl group from cytoplasm into the
periplasm, are highly conserved and interchangeable
between different serotypes. Whereas, the third gene,
gtr(type) is unique to each serotype and encodes a
glucosyltransferase that is responsible for attaching the
glucosyl group to a specific sugar unit of the O-antigen
via a specific linkage [8-14]. In contrast, the addition of
an O-acetyl group is mediated by only one protein, an
O-acetyltransferase encoded by the oac gene of phage
Sf6 [15].
Five serotype converting bacteriophages: SfI, SfII, SfV,
SfX and Sf6, have previously been isolated and studied
[12,15-19]. Lysogenisation of these bacteriophages have
been shown to convert serotype Y strains to serotype 1a,
2a, 5a, X and 3b, respectively, and the gtrI, gtrII, gtrV,
gtrX, and oac genes, which are involved in the serotype
conversion have been characterized. Analysis of the
phage genomes has also revealed that in all these phages,
the genes involved in serotype conversion are located
adjacent to the int attP region, and the phage DNA (ex-
cept Sf6) has integrated into the thrW gene, in the pro–
lac region of the host genome [7].
The type IV O-antigen modification genes from S.
flexneri 4a strains have been characterized and shown to
convert serotype Y strain to serotype 4a. Also, analysis of
the fragment of DNA upstream of the gtrA gene in sero-
type 4a strain has revealed the presence of bacteriophage
int gene and attP site [8]. However, attempts to isolate a
serotype converting SfIV bacteriophage have not been
successful to date.
In this study, we report the isolation and char-
acterization of bacteriophage SfIV, induced from a
wildtype S. flexneri 4av strain. The complete sequence
of phage SfIV was determined and compared to other
known Shigella serotype converting phages at the pro-
tein level. Our results suggest that the SfIV phage was
similar to SfII and SfV phages, and there was a consider-
able conservation in the genomic architecture of all the
phages. Five proteins identified were unique to SfIV,
four of which could potentially play a role in pathogen-
esis of its host.Methods
Bacterial strains, phage and media
Bacteriophage SfIV was isolated from S. flexneri 4av
strain (SFL1522, International Centre for Diarrhoeal
Disease Research, Bangladesh) using the UV irradiation
protocol described by Adams et al. [8]. Plaque assays
were performed on the lysate after induction. Bacterio-
phage stocks were prepared by picking a single plaque,
propagating on serotype Y strain (SFL124) [20], and pre-
cipitating phage using polyethylene glycol, as described
in Sambrook et al. [21].
Phage was routinely propagated in NZCYM broth and
S. flexneri strains were grown in Luria–Bertani (LB) broth
or LB agar.
Electron microscopy
For electron microscopy, phage preparations were nega-
tively stained with 2% phosphotungstic acid (pH 7.0)
and electron micrographs were taken with a Hitachi
H600 transmission electron microscope.
Determination of phage host range and lysogens
To determine the host range of bacteriophage SfIV, dif-
ferent dilutions of the purified phage stock were made in
SM buffer (100 mM NaCl, 50 mM Tris–HCl pH 7.5,
8 mM MgSO4 and 0.002% (w/v) gelatin). 100 μl of over-
night culture of the required bacterial host strain was
then spread on the LB agar plate. Once the plates were
dry, 5–10 μl of the phage stock of different dilutions was
spotted on the plate. The plates were incubated over-
night at 37°C and were examined for appearance of the
clear zones around the phage drop.
Lysogens of SfIV were obtained using the method pre-
viously described by Marvis et al. [12].
Genomic DNA purification and sequencing
Bacterial genomic DNA was isolated using GE Healthcare
genomic DNA isolation kit (GE Healthcare), according to
the manufacturer’s instructions. Complete genome of the
host strain SFL1522 was sequenced using 250 bp paired-
end, Miseq, Illumina sequencing (performed at the
Ramaciotti Centre, University of New South Wales). Reads
generated were then assembled into contigs using CLC
Genomics Workbench (Ver 5.5.1, CLC Bio). The contigs
containing the gtrA and the int gene were extracted. The
gaps between the desired contigs were filled by designing
primers binding to the end of each contig and amplifying
the segment using SFL1522 genomic DNA. PCR product
obtained was further purified using the gel purification kit
(Promega) according to the manufacturer’s instructions.
Purified PCR product was then sequenced using the ABI
Prism BigDye Terminator Cycle Sequencing Ready reac-
tion kit, and the reactions were performed in a GeneAmp
2400 thermal cycler (Perkin Elmer) according to the
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Prism 377 Automated sequencer at the Biomedical Re-
sources Facility, John Curtin School of Medical Research,
Australian National University.Sequence assembly and analysis
The contigs were assembled using CLC Genomics Work-
bench (Ver 5.5.1, CLC Bio) and the open reading frames
(orfs) were determined using the NCBI ORF finder pro-
gram and CLC Main Workbench (Ver 6.6.2, CLC Bio).
The genome was scanned for tRNA using tRNAscan-SE
Search server [22], and the Rho-independent terminators
were identified using ARLOND terminator finding pro-
gram [23].Genome comparison
Multiple genome alignment was performed using Mauve
[24], and the protein level alignments were perfomed
using ClustalW [25]. The accession numbers for the
phages used for comparative genomics were: Entero-
bacteria phage SfI (JX509734), Shigella phage SfII
(NC_021857), Enterobacteria phage SfV (NC_003444),
phage SfX (NC_017328), Shigella phage Sf6 (NC_005344),
Enterobacteria phage cdtI (NC_009514), Enterobacteria
phage lambda (NC_001416), Enterobacteria phage phiP27
(NC_003356), Enterobacteria phage Mu (NC_000929),
StxI phage (AP005153), Salmonella phage epsilon34
(NC_011976), Salmonella phage ST64B (NC_004313),
Salmonella phage ST64T (NC_004348), Enterobacteria
phage ST104 (NC_005841), and Salmonella phage SE1
(DQ003260).Availability of supporting data
The nucleotide sequence of SfIV phage reported in this
article has been deposited in the GenBank database as
accession number KC814930.Figure 1 Electron micrograph of bacteriophage SfIV. Electron
micrograph of phage SfIV, stained with 2% phosphotungstic acid.
Bar 100 nm.Results and discussion
Isolation of bacteriophage SfIV
SfIV phage was induced from serotype 4av, strain
SFL1522. Clear plaques were produced when the lysate
after induction from SFL1522 was plated onto the indi-
cator strain SFL124 (serotype Y). The colonies isolated
from turbid areas of the plaques were assessed by slide
agglutination, PCR and SfIV infection. Colonies showing
positive agglutination with both: group 3,4 (specific for
serotype Y) and type IV antisera (specific for serotype
IV), were assumed to be lysogens. Results of PCR ampli-
fication and SfIV infection indicated that the lysogens
contained the SfIV-specific gtrIV gene and were resistant
to SfIV infection.Morphology of SfIV
Electron microscopy was used to determine bacterio-
phage SfIV morphology. Electron micrographs revealed
that the SfIV phage particle has an isometric head of ca.
55 nm and a long contractile tail of ca. 101 nm (Figure 1).
It is a typical group ‘A’ phage, of the family Myoviridae,
and order Caudovirales, according to the morphological
classification of Bradley [26]. Appearance of SfIV also re-
sembles other serotype converting phages of Shigella, like
SfV [17], SfII [12] and a newly isolated phage SfI [19].
Host range of phage SfIV
The host range of the SfIV bacteriophage was deter-
mined with twelve serotypes (1a, 1b, 1c, 2a, 2b, 3a, 3b,
4a, 4b, 5a, X, and Y) of S. flexneri. Of the serotypes ex-
amined, SfIV was capable of infecting serotypes: 1a, 1b,
1c, X and Y. This suggests that, in comparison to other
morphologically similar Shigella phages, SfIV has a much
broader host range than SfI (infects only X and Y sero-
types) [19], and SfII (infects serotypes 3a, 5a and Y), but
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4b, and Y) [27]. Surprisingly, there is very little similarity
between the host range of these bacteriophages, with sero-
type Y being the only common serotype infected by all the
four phages.
Determination of the phage SfIV genomic sequence
The complete DNA sequence of bacteriophage SfIV was
determined using a combination of Illumina (Miseq) and
PCR sequencing. High throughput sequencing of the
host (SFL1522) DNA, generated 4,32,905 pairs of reads,
which is about 25 fold genome coverage. The genomic
sequence was then de-novo assembled into 700 contigs
and scaffolds using the CLC Genomics Workbench (Ver
5.5.1, CLC Bio). The accuracy of the CLC assembly was
further verified using another assembly tool, Velvet [28],
and by mapping the reads back to the contigs.
SfIV phage genome was distributed between two contigs
of 27 kb and 14 kb. The gap between the two contigs was
then closed by targeted PCR and subsequent sequencing,
yielding a contiguous prophage SfIV genome flanked by
the int and gtrA gene. 46 bp attp site (identical to phage
SfI and SfV) was identified on either ends of the prophage
DNA, and was used to construct a circular SfIV bacterio-
phage genome. The linear orientation of the sequence
starting from small terminase gene and ending with the
cos site was then used for further analysis.
The genome of SfIV consists of 39,758 bp with an
average GC content of 50.29%, which is very similar to
its host (50.90%). The bioinformatics analysis revealed a
total of 54 orfs, taking up to 90.05% of the coding cap-
acity of this virus. A plausible Shine-Dalgarno sequence
and a start codon (44 with ATG, 9 with GTG and 1 with
TTG) were identified for all the orfs. Thirty eight puta-
tive SfIV genes are transcribed rightwards (on the gen-
etic map), while sixteen genes transcribed leftwards
(Figure 2). The protein corresponding to each orf wasFigure 2 Genetic map of bacteriophage SfIV. The SfIV phage genome is
predicted open reading frames, with the arrowheads indicating the directio
above. The attP/cos site is indicated in red. The Rho-independent terminatothen compared with the non-redundant protein databases
using the NCBI BlastP tool. The database search yielded
matches with other proteins with identity values between
33% to 100% (Additional file 1: Table S1). The genome of
bacteriophage SfIV was also scanned for the presence of
tRNA’s and Rho-independent termiantors. The predicted
Rho-independent terminators are summarized in Figure 2,
however, no tRNA genes were identified.
Comparison of SfIV with other serotype converting
phages of S. flexneri
The genome of bacteriophage SfIV was first compared
to 15 previously sequenced phages from various hosts: S.
flexneri (5), E. coli (5), and Salmonella (5), using Mauve
(Additional file 2: Figure S1). The results of multiple
alignment revealed that the SfIV bacteriophage had high
degree of DNA sequence similarity with other serotype
converting bacteriophages of S. flexneri in particular SfI,
SfII and SfV, but not with SfX and Sf6. Considerable
similarity was also obtained with two E. coli phages:
phage phiP27 and phage cdtI, and one Salmonella phage
ST64B. Rest of the lambdoid phages showed limited
silmilarity to SfIV, with phage Mu showing no similarity
at all. To get a better understanding of the degree of re-
latedness among the Shigella phages, bacteriophage SfIV
encoded proteins were compared with those of other
serotype converting phages of S. flexneri (Figure 3).
orf-1 and orf-2, encode the phage SfIV small and large
terminase subunits, respectively, which are required for
packaging bacteriophages dsDNA into the cavity of
preformed protein shells called proheads [29]. The
terminases of bacteriophage SfIV show high amino acid
level identity (>90%, Figure 3) with the terminases of
bacteriophage SfI, SfII and SfV, suggesting that the
packaging mechanism is same in these phages. This was
verified by the genome sequence analysis of phage SfIV
which revealed a cos site identical to phage SfI, SfII andshown with a scale in bp. The arrows above the scale represent
n of transcription. Putative function and names of genes are given
rs are indicated as black knobs below the scale.
Figure 3 Comparison of SfIV with other serotype converting phages of S. flexneri. Protein corresponding to each orf was compared with its
equivalent protein in SfI, SfII, SfV, Sf6 and SfX phages using ClustalW. The arrows below the SfIV map are colour coded and represent the amino
acid sequence identity between the SfIV proteins and their equivalents in other phages. The colour codes are:- red: 90-100% identity, yellow:
80-89% identity, orange: 70-79% identity, green: 60-69% identity, blue: 50-59% identity and grey: 10-50% identity. The purple arrows in the SfIV
map represent the unique proteins of phage SfIV.
Jakhetia et al. BMC Genomics 2013, 14:677 Page 5 of 8
http://www.biomedcentral.com/1471-2164/14/677SfV. Thus, like SfI, SfII, and SfV, phage SfIV uses bac-
teriophage lamba like packaging in which virion ge-
nomes are generated by cos site specific DNA cleavage
at the beginning and at the termination of every pack-
aging event. This results in all the virions with DNA of
identical, specific ends, generating only precise frag-
ments on restriction digestion. Furthermore, very lim-
ited similarity observed between the terminases of SfIV,
Sf6 and SfX could be because of the different packaging
mechanisms used by Sf6 and SfX. The packaging mech-
anism of bacteriophage Sf6 and SfX is like phage P22, in
which the terminases bind to the pac recognition site,
and the DNA is packaged by the headful mechanism
[15,29,30].
Databases homology searches suggested that orf-3, orf-
4 and orf-5 encode the bacteriophage portal protein,
prohead protease and major head protein, respectively
(Additional file 1: Table S1). Protein alignment results
have shown that these three proteins of SfIV share >90%
identity with their counterparts in phage SfI and SfII,
but very little identity was obtained with those of SfV.
However, it should be noted that even though the SfV
proteins show little amino acid similarity, they still be-
long to the HK97 family of proteins (like SfI, SfII and
SfIV). Thus, like several other proteins from tailed bac-
teriophages, these could be divergent homologues show-
ing conserved structure and function [31]. In contrary,
viral capsid assembly proteins in bacteriophage Sf6 and
SfX are different. The coat protein of Sf6 is similar to that
of bacteriophage P22 and is known to include surface ex-
posed domain (a conserved feature specific to P22 likebacteriophages) with an “HK97-like” core [32]. In addition,
Sf6 bacteriophage also contains a separate scaffold protein
and three other head completion genes [15].
Analysis of proteins encoded by orf-6 through orf-21
suggests that this region of the SfIV genome is involved
in bacteriophage tail structure and assembly (Additional
file 1: Table S1). The major difference between the tail
proteins of SfIV and other 3 phages (SfI, SfII and SfV)
was ORF-12, ORF-13 and ORF-22. While ORF-12 (a
hypothetical protein) and ORF-13 (a tail tape measure
protein) of SfIV showed <50% identity with SfI (ORFs 15
and 16), SfII (ORFs 15,16), and SfV (ORFs 13,14), ORF-
22 which is a predicted tail fiber assembly protein was
completely missing in SfI, SfII and SfV. Since phage tail
fibers bind to the receptors on the bacterial host for ad-
sorption [33], presence of an additional tail fiber assem-
bly protein in SfIV could explain the fact that the host
range of SfIV does not match with the above mentioned
three phages. Unlike SfI, SfII, SfIV, and SfV (which be-
long to group A1), phage Sf6 and SfX are members of
class C bacteriophages, consisting of icosahedral head
and a short tail. Thus, unlike SfIV, Sf6 and SfX have only
one protein in the tail spike module [34].
SfIV phage orfs 25–27 encode for the O-antigen modi-
fication cluster. orf-25 corresponds to the gtrIV gene, the
serotype specific modification gene [8]. orfs 26 and 27,
encode for the gtrBIV and gtrAIV, respectively. As expected,
no protein level similarity was observed between the type
specific modification genes of the six bacteriophages.
However, the gtrA and gtrB genes were highly conserved
(with >90% protein level identity). The integrase and
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were also conserved between SfI, SfII, SfIV and SfV. How-
ever, when compared with the Int and Xis of Sf6 and SfX,
very little identity was observed with proteins of both Sf6
and SfX phage. Different Int protein of Sf6 could explain
its integration into agrW, instead of thrW tRNA gene [7].
orfs 30–34 encode for hypothetical proteins with no
clear functions. While these proteins were completely
missing in SfI, Sf6 and SfX, the same cluster of unknown
genes was observed in SfV (orfs 28–32) and was found
to share >98% protein level identity with SfIV proteins.
The homologues of ORFs −30, -31 and −32 were present
in SfII as well (ORFs 32, 33 and 34), however, ORF-33 of
SfIV was missing in SfII, and ORF-34 showed only 85%
identity with ORF35 of SfII.
In all the lambdoid phages, the regulatory switch that
determines whether the phage will follow a lytic or lyso-
genic cycle includes an operator/promoter sequence and
two major proteins similar to the Cro and cI repressor
proteins of phage lambda. Analysis of the SfIV genome
revealed that the orfs −37 and −38 encode for the cI and
Cro proteins, which are 100% identical with the cI and
Cro of SfV. The cI and Cro proteins of SfI, SfII, Sf6 and
SfX, however, showed very limited identity to SfIV. Ana-
lysis of the SfIV sequence for additional lambda regula-
tory elements CII, cIII, or N proteins, revealed that like
SfII and SfV, SfIV does not contain any additional regu-
latory factors, although these factors were present in the
other three phages (SfI, Sf6 and SfX).
The blastp search results have also revealed that the
SfIV orf −39 and −40 encode for a putative DNA-
binding regulatory protein, and an unknown protein,
which had >90% identity to SfII ORFs 39 and 40 pro-
teins. The replication module of SfIV which stretches
from orf-41 to orf-45, showed high identity to the corre-
sponding proteins of SfII and SfV, but was not present
in the SfI, Sf6 and SfX genome sequences. Intrestingly,
most of the replication module of SfIV was similar to
SfII and SfV, however, the methylase gene present in SfII
and SfV replication module was not found in SfIV.
The antitermination Q protein encoded by orf-46 reg-
ulates the expression of lamdoid phage lytic proteins by
modifying the RNA polymerase near the phage late gene
promoter allowing it to pass one or more terminators
[35]. The antitermination Q protein of SfIV was very dif-
ferent from all the other phages, sharing <50% identity
with its equivalents. The lytic cassette of SfIV consists of
holin, lysin, Rz and Rz1 proteins (encoded by orfs 50–
53). These proteins share high degree of identity with
their counterparts in SfII and SfV, but are different to
their equivalents in SfI, Sf6 and SfX. Like bacteriophage
lambda, the lytic cassette of Sf6 and SfX contains holin
with a dual start motif (resulting in production of holin
and anti-holin by the same gene) that regulates thetiming of lysis [36]. However, the mechanism of control-
ling the timing of lysis in SfI, SfII, SfIV and SfV is not
known. orf-54 the last gene of SfIV encodes for a HNH
endonuclease domain protein which had homologues in
SfI, SfII, and SfV, but not in Sf6 and SfX. Given that the
orf-54 is a member of phage late genes and its homologues
were only observed in the Shigella phages lacking the dual
start motif of holin, it could be hypothesized that this pro-
tein plays a role in controlling the timing of lysis.
Proteins unique to phage SfIV
There were several proteins in the SfIV genome (high-
lighted in purple, Figure 3), which did not have homo-
logues in any other serotype converting phages of S.
flexneri. These are: ORF-22, a tail fiber protein (discussed
earlier), ORFs −23, -24 identified as insertion elements
ISEhe3 Orf B, ISEhe3 Orf A, respectively, and ORFs −35
and −36 proteins with no clear function. These two un-
known proteins are potential candidates for future viru-
lence studies as several bacteriophages are known to
encode factors that alter host properties relevant to vari-
ous stages of infection [37-39]. The region between
antitermination Q and lytic cassette (orfs 47–49) was iden-
tified as a moron. Like a typical moron, this region is
flanked by transcription initiation and termination signals.
Moreover, analysis of the GC content has revealed that
this region has a significantly lower GC content (39.20%)
than the rest of the SfIV phage (50.29%). orf-47 encodes
for a transposase (IS1 Transposase B). Based on this, we
hypothesize that orf-48 and orf-49, came with orf-47 in
the SfIV genome from another species. As morons are
expressed in lysogens and are known to confer selective
advantage to the host [16], it is reasonable to assume
that the unknown proteins encoded by orfs −48 and −49
could be involved in the pathogenesis of its host
bacterium.
Conclusions
This is the first report on isolation of a serotype
converting bacteriophage SfIV from a wildtype S. flexneri
4av strain. The complete genome sequence of phage SfIV
was determined, and the comparison between SfIV and
other S. flexneri serotype converting phages was obtained
at the protein level. The analysis revealed that the SfIV
phage was more closely related to SfII and SfV, than the
rest of the phages. Nevertheless, SfIV phage was found to
contain five proteins which were not present in any other
phages of S. flexneri and may potentially be involved in
the pathogenesis of its host. Moreover, the comparison
study also indicated that the general organization of the
genes was similar in all the phages. Further molecular bio-
logical studies based on the comparative genomic analyses
of these phages will be useful in elucidating the evolution
of these related phages. It will also provide essential
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and therapeutic agents to control infection caused by S.
flexneri.
Additional files
Additional file 1: Table S1. Analysis of predicted orfs and proteins of
SfIV.
Additional file 2: Figure S1. DNA sequence alignment of SfIV phage
with other related phages. The alignment of SfIV phage with other
phages from S. flexneri, E. coli and Salmonella. The results obtained using
Progressive Mauve with default parameters showing high degree of
similarity of SfIV with S. flexneri phage SfII, SfV and SfI. Coloured outlined
blocks surround regions of the genome that aligned to part of another
genome. The degree of DNA sequence similarity is indicated by the
height of the coloured bars inside the blocks.
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